Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.97
+0.05 (0.50%)
Nov 20, 2024, 4:00 PM EST - Market closed
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $490.27 million as of November 21, 2024. Its market cap has decreased by -4.60% in one year.
Market Cap
490.27M
Enterprise Value
443.89M
1-Year Change
-4.60%
Ranking
Category
Stock Price
$9.97
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $490.27M, a decrease of -33.81%. That is a compound annual growth rate of -3.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 490.30M | -12.40% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GH Research | 499.99M |
| Olema Pharmaceuticals | 499.29M |
| GRAIL | 496.96M |
| PureTech Health | 491.58M |
| Arcturus Therapeutics Holdings | 489.20M |
| Y-mAbs Therapeutics | 486.41M |
| Treace Medical Concepts | 483.43M |
| Zevra Therapeutics | 478.78M |